Lysosomal Therapeutics

About:

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

Website: http://lysosomaltx.com

Top Investors: Hatteras Venture Partners, Atlas Venture, Partners Innovation Fund, Roche Venture Fund, Orion Healthcare Equity Partners

Description:

Lysosomal Therapeutics is dedicated to innovative small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases. Their strategy leverages the clinically-validated link between lysosome-based genetic disorders and neurodegenerative diseases to establish a unique and effective molecular platform for novel drug discovery. LTI’s lead program targets Gaucher-related neurodegeneration, Parkinson’s disease, and other synucleinopathies.